-+ 0.00%
-+ 0.00%
-+ 0.00%

Elevance Health Q3 2026 net income rises 13% year over year to $1.34 billion

PUBT·10/21/2026 10:04:26
Listen to the news
Elevance Health Q3 2026 net income rises 13% year over year to $1.34 billion
  • Elevance Health’s third-quarter 2026 diluted earnings rose 18% year over year to $6.27 per share.
  • Operating revenue increased year over year to $50.44 billion, supported by higher premium yields, CarelonRx product revenue and service fees.
  • Health Benefits operating gain fell 27% year over year to $436 million, reflecting targeted investments supporting its long-term operating model.
  • The full-year 2026 outlook calls for diluted earnings of at least $22 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261020437030) on October 21, 2026, and is solely responsible for the information contained therein.